Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |